Maribavir for Prevention of CMV After Stem Cell Transplants

NCT00223925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

DRUG: Maribavir
DRUG: Placebo

Sponsor

Shire